[1] Goldring SR.  Pathogenesis of bone and cartilage destruction in rheumatoid arthritis[J]. Rheumatology(oxford), 2003, 42(Suppl 2): ii11-ii16.
[2] McInnes IB, Leung BP, Liew FY.  Cell-cell interactions in synovitis.Interactions between T lymphocytes and synovial cells[J]. Arthritis Res, 2000, 2(5): 374-378.   doi: 10.1186/ar115
[3] Schett G, Tohidast-Akrad M, Smolen JS, et al.  Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis[J]. Arthritis Rheum, 2000, 43(11): 2501-2512.   doi: 10.1002/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K
[4] Johnson GL, Lapadat R.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases[J]. Science, 2002, 298(5600): 1911-1912.   doi: 10.1126/science.1072682
[5] Wolfe F, Rasker JJ, Boers M, et al.  Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis[J]. Arthritis Rheum, 2007, 57(6): 935-942.   doi: 10.1002/art.22895
[6] 潘为民, 谭天秩, 王全林, 等.  云克联合免疫抑制剂治疗活动期Graves'眼病患者[J]. 生物医学工程学杂志, 2002, 19(2): 300-301.   doi: 10.3321/j.issn:1001-5515.2002.02.030
[7] 丁和义.  云克治疗类风湿关节炎的临床应用[J]. 中华现代临床医学杂志, 2003, 1(1): 37-38.
[8] Huang A, Yu L, Shen L.  Effect of technetium-99 conjugated with methylene diphosphonate on IgM-RF, IgG-RF and IgA-RF[J]. J Huazhong Univ Sci Technolog Med Sci, 2003, 23(3): 266-268.   doi: 10.1007/BF02829509
[9] 李媛, 齐文成.  99Tc-MDP、甲氨蝶呤分别联合爱若华治疗类风湿关节炎疗效比较[J]. 当代医学, 2009, 15(7): 123-124.   doi: 10.3969/j.issn.1009-4393.2009.07.099
[10] 胡秀芳, 史素琴, 徐涛.  99Tc-MDP联合中药治疗类风湿关节炎的疗效观察[J]. 四川中医, 2005, 23(6): 39-40.   doi: 10.3969/j.issn.1000-3649.2005.06.022
[11] Portenoy RK, Lesage P.  Management of cancer pain[J]. Lancet, 1999, 353(9165): 1695-1700.   doi: 10.1016/S0140-6736(99)01310-0
[12] Boyle WJ, SimonetWS, Lacey DL.  Osteoclast differentiation and activation[J]. Nature, 2003, 423(6937): 337-342.   doi: 10.1038/nature01658
[13] 马丽, 陈正福, 张学敏.  云克(99Tc-MDP)治疗恶性肿瘤转移性骨痛近期疗效观察[J]. 航空航天医药, 2007, 18(3): 154-155.   doi: 10.3969/j.issn.2095-1434.2007.03.012
[14] Kaneko M, Nomura Y.  ER signaling in unfolded protein response[J]. Life Sci, 2003, 74(2-3): 199-205.   doi: 10.1016/j.lfs.2003.09.007
[15] 桑士标, 吴翼伟, 苏成海, 等.  云克治疗强直性脊柱炎的临床研究[J]. 苏州大学学报(医学版), 2006, 26(6): 1021-1022.
[16] 桑士标, 李清茹, 吴翼伟, 等.  云克治疗甲亢伴浸润性突眼的疗效分析[J]. 苏州大学学报(医学版), 2005, 25(6): 1106-1107.
[17] 韦智晓, 李俊红, 覃伟武, 等.  云克配合131Ⅰ治疗Graves病合并Graves眼病的近期疗效[J]. 中国医学影像技术, 2008, 24(10): 1644-1646.   doi: 10.3321/j.issn:1003-3289.2008.10.045
[18]

潘中允. 放射性核素治疗学. 北京: 人民卫生出版社, 2006: 492-509.
[19] 高克加, 戚文骥, 毛诚忠, 等.  "云克"治疗股骨头无菌性坏死[J]. 中华核医学杂志, 2003, 23(2): 86-.
[20] Abe E, Yamamoto M, Taguchi Y, et al.  Essential requirement of BMPs-2/4 for postnatal osteoblasts and oateoclast formation in murine bone marrow cultures from adult mice: antegonism by noggin[J]. J Bone Miner Res, 2000, 15(4): 663-673.
[21] 张萌萌, 窦宇, 郭忠, 等.  99Tc-MDP对绝经后骨质疏松骨吸收、骨生成的影响[J]. 中国实验诊断学, 2005, 9(2): 255-256.   doi: 10.3969/j.issn.1007-4287.2005.02.035